Abstract N-Methyl-D-aspartate (NMDA) receptor antagonists are known to rescue neuronal cell death caused by excessive activation of glutamate receptors. This phenomenon, known as excitotoxicity, is implicated in the pathogenesis of several neurodegenerative disorders including ischemia, Alzheimer's disease, Parkinson's disease, and Huntington's disease. Unfortunately, some NMDA receptor antagonists have shown discouraging results when tested in clinical trials. However, recent advances in the physiology and pharmacology of the NMDA receptor have kept interest alive in modulating NMDA receptors for therapeutic intervention. We present here the synthesis of a small library of phenylalaninol-derived oxazolopyrrolidone lactams and their evaluation as NMDA receptor antagonists. The compounds were easily synthesized in yields up to 92 %. In addition, one of the compounds has a 50 % inhibitory concentration (IC 50 ) of 62 lM and offers potential to develop more potent NMDA receptor antagonists.
Introduction
N-Methyl-D-aspartate receptors (NMDAR) are part of the family of ionotropic glutamate receptors. After activation by their co-agonists, glycine and glutamate, they allow neural influx of Ca 2? through a membrane ion pore, thus playing an important role in postsynaptic depolarization [1] [2] [3] [4] . Apart from their involvement in synaptic plasticity, which has been postulated as the neurochemical basis of learning and memory, NMDA receptors have been implicated in neuronal death [5] . High levels of glutamate have been found in brain trauma and other neurodegenerative diseases, so it is thought that NMDA receptors are potential targets for neuroprotective compounds [6] . In fact, the adamantanes amantadine and memantine develop their neuroprotective effects through blockade at the NMDA receptor. Specifically, memantine is authorized in Western countries and used therapeutically to slow the progression of Alzheimer's disease [7] .
In 2009, some orally active oxazolidine derivatives were described to act as NMDA antagonists by preventing binding of NMDAR ligands [8] . Based on this information and due to our interest in the synthesis of oxazolo lactams [9, 10] , we decided to extend our research to synthesis of enantiopure oxazolopyrrolidone lactams using (S)-phenylalaninol as a chiral inductor. Since the biological activity is greatly affected by the absolute stereo-outcome of the compounds, a series of (R)-phenylalaninol derivatives was also prepared.
Results and discussion

Synthesis
Recently, our research group has been interested in synthesis of phenylalaninol-derived oxazolopyrrolidone lactams to be evaluated as NMDA receptor antagonists. The first series of compounds was synthesized by cyclocondensation of (S)-phenylalaninol (1) with oxoacids 2a-2e (Scheme 1). In turn, tricyclic lactams 3a-3c were prepared from 2-acylbenzoic acid derivatives 2a-2c via reflux in toluene under Dean-Stark conditions (Table 1) . Starting from oxoacids 2d, 2e and using the same reaction conditions, we obtained the bicyclic lactams 3d, 3e in 72-73 % yields (Table 1) . In all cases, only one diastereoisomer product was observed.
To study the effect of the corresponding enantiomers as antagonists at the NMDA receptor, lactams 3a 0 -3c 0 were also synthesized starting from (R)-phenylalaninol with 62-85 % yields (Table 1 ; Scheme 2).
NMR spectroscopy
The most important features of the 1 H nuclear magnetic resonance (NMR) spectra of these compounds are the resonances of the H-3, H-2, and CH 2 0 underwent nuclear Overhauser spectroscopy (NOESY) experiments, and it was possible to observe the correlations depicted in Fig. 1 . As expected and in accordance with published results for very similar compounds [9] synthesized via cyclocondensation with an enantiopure aminoalcohol, the stereo-outcome does not seem to be affected by the size of the keto-acid R substituent.
NMDA receptor antagonist activity
The NMDA receptor activity of the compounds was evaluated by measuring their ability to inhibit the intracellular calcium increase induced by NMDA in cultured cerebellar granule neurons. Addition of glutamate or NMDA (100 lM) in the presence of glycine (10 lM) produced a robust and stable increase in intracellular calcium that was challenged with cumulative additions of the compounds to be tested.
In our assays, memantine (used as a positive control) yielded an IC 50 value in the low micromolar range (1.48 lM). As shown in Fig. 2 , only three out of the eight synthesized compounds showed inhibitory activity higher than 50 % of maximal effect. Specifically, 3c and 3d showed IC 50 in the high micromolar range ([250 lM), while 3e showed higher potency as a NMDA antagonist, giving an IC 50 of 62.0 lM. Related to compound 3c, which showed an IC 50 of 309.7 lM, the enantiomer 3c 0 was inactive, so it seems that the stereochemistry at the 3-position is important for activity. More importantly, the phenyl derivative 3e is more potent as an NMDA receptor antagonist than amantadine (92.0 lM).
In summary, we have synthesized and fully characterized several phenylalaninol-derived oxazolopyrrolidone lactams. In addition, we describe herein the potential use of lactam 3e as a hit compound to develop NMDA receptor antagonists. These data provide a basis for exploring whether related derivatives have enhanced activity. The synthesis and biological evaluation of more compounds related to 3e are underway.
Experimental
All reagents and solvents were obtained from commercial suppliers and were used without further purification. Melting points were determined using a Kofler camera Bock monoscope M. The infrared spectra were collected on a Shimadzu IRAffinity-1 Fourier-transform infrared (FT-IR) spectrophotometer. Low-resolution mass spectroscopy (MS) was performed in LCLEM, Faculdade de Farmácia, Universidade de Lisboa. Merck silica gel 60 F 254 plates were used for analytical thin-layer chromatography (TLC); flash column chromatography was performed on Merck silica gel (200-400 mesh).
1 H and 13 C NMR spectra were recorded on a Bruker 400 MHz Ultra-Shield. Proton nuclear magnetic resonance spectra were recorded at 400 MHz. Carbon nuclear magnetic resonance spectra were recorded at 100 MHz.
1 H and 13 C NMR chemical shifts are expressed in d (ppm) referenced to the solvent used and the proton coupling constants J in hertz (Hz). Spectra were assigned using appropriate correlation spectroscopy (COSY), distortionless enhancement by polarization transfer (DEPT), and heteronuclear multiple quantum coherence (HMQC) sequences.
General procedure for the cyclocondensation reaction of (S)-2-amino-3-phenylpropan-1-ol (1) with keto-acids 2a-2e
To a stirred solution of (S)-2-amino-3-phenylpropan-1-ol in boiling toluene under inert atmosphere and a Dean-Stark apparatus was added 1.1 eq. of the desired oxo-acid. The mixture was refluxed until total consumption of the starting aminoalcohol. The solvent was evaporated and the crude residue was purified by column chromatography using ethyl acetate/n-hexane as eluent. The solid products were recrystallized in diethyl ether/n-hexane.
Prepared from 90 mg of (S)-2-amino-3-phenylpropan-1-ol in 10 cm 3 of toluene. The obtained residue was purified by column chromatography (AcOEt:n-hexane 3:7). Recrystallization from diethyl ether/n-hexane afforded 110 mg (70 %) 3a. The 1 H NMR spectrum was found to be identical with the one described in Ref. [11] .
Prepared from 330 mg of (S)-2-amino-3-phenylpropan-1-ol in 30 cm 3 of toluene. The obtained residue was purified by column chromatography (AcOEt:n-hexane 3:7) affording 560 mg (92 %) of 3b as a colorless oil. ? ; R f (ethyl acetate:n-hexane 3:7) = 0.61.
Prepared from 100 mg of (S)-2-amino-3-phenylpropan-1-ol in 10 cm 3 of toluene. The obtained residue was purified by column chromatography (AcOEt:n-hexane 1:1) affording 111 mg (73 %) of 3d as a colorless oil. The 1 H NMR spectrum was found to be identical with the one described in Ref. [12] .
Prepared from 100 mg of (S)-2-amino-3-phenylpropan-1-ol in 10 cm 3 of toluene. The obtained residue was purified by column chromatography (AcOEt:n-hexane 3:7). Recrystallization from diethyl ether/n-hexane afforded 140 mg General procedure for the cyclocondensation reaction of (R)-2-amino-3-phenylpropan-1-ol (1 0 ) with keto-acids 2a-2c
To a stirred solution of (R)-2-amino-3-phenylpropan-1-ol in boiling toluene under inert atmosphere and a Dean-Stark apparatus was added 1.1 eq. of the desired oxo-acid. The mixture was refluxed until total consumption of the starting aminoalcohol. The solvent was evaporated and the crude residue was purified by column chromatography using ethyl acetate/n-hexane as eluent.
Prepared from 100 mg of (R)-2-amino-3-phenylpropan-1-ol in 15 cm 3 of toluene. The obtained residue was purified by column chromatography (AcOEt:n-hexane 2:8). Recrystallization from diethyl ether/n-hexane afforded 125 mg (71 %) 3a 0 . The 1 H NMR spectrum was found to be identical with the one described in Ref. [11] .
0 , C 18 H 17 NO 2 ) Prepared from 100 mg of (R)-2-amino-3-phenylpropan-1-ol in 15 cm 3 of toluene. The obtained residue was purified by column chromatography (AcOEt:n-hexane 2:8) affording 157 mg (85 %) of a colorless oil.
1 H NMR, 13 C NMR, and IR spectra were found to be identical with the ones described for compound 3b.
Prepared from 100 mg of (R)-2-amino-3-phenylpropan-1-ol in 15 cm 3 of toluene. The obtained residue was purified by column chromatography (AcOEt:n-hexane 2:8). Recrystallization from diethyl ether/n-hexane afforded 167 mg (74 %) of 3c 0 . 1 H NMR, 13 C NMR, and IR spectra were found to be identical with the ones described for compound 3c.
NMDA receptor antagonist activity
The activity of the synthesized compounds as NMDA receptor antagonists was evaluated using primary cultures of rat cerebellar neurons, as described previously [13] . Briefly, cultures were prepared from 7-8-day-old Wistar rats (Charles River, France). Cerebella were dissected, minced, and trypsinized, and after several sedimentations, cells were plated on poly-lysinized coverslips placed in 24-well plates at density of 1 9 10 6 cells/cm 3 . Plates were kept at 37°C in a cell incubator (Heraeus, Germany). After 16-18 h, 10 lM cytosine arabinoside (Sigma-Aldrich, USA) was added to avoid excessive proliferation of astrocytes. Cultures prepared in this manner are ready to be used in NMDA receptor activity assays from the 7th to 11th day in vitro.
Activity at the NMDA receptor was assessed using the calcium-sensitive probe fura-2 (Invitrogen, USA). After incubation with 6 lM fura-2 acetoxymethyl ester (fura-2 AM) for 30-45 min at 37°C, a coverslip was transferred to a plastic holder that was inserted into a quartz cuvette for fluorescence measurements. Recordings of fura-2 fluorescence were performed using a PerkinElmer LS50B luminescence spectrometer, at both 340 and 380 nm excitation wavelengths, and at 510 nm emission. The ratio F 340 /F 380 (R) is proportional to intracellular calcium. All measurements were made at 37°C and under mild stirring. Once the recording was started, glycine (10 lM) and NMDA (100 lM) were added to the cuvette, at 50 and 100 s, respectively. This produced a sustained increase in F 340 /F 380 , indicating that the NMDA receptors were activated and that the intracellular calcium concentration was high. This intracellular calcium increase was challenged with cumulative concentrations of the compounds under investigation (from 1 9 10 -7 up to 3 9 10 -4 M). If the compounds would act as antagonists at the NMDA receptor this would be detected as a decrease in the F 340 /F 380 value. Experiments were performed in triplicate. Memantine was used as a positive control. When a minimum of 50 % of inhibition was reached, the IC 50 value was calculated using nonlinear regression with GraphPad Prism 5.0.
